Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Anatomic chronic emphysema was excluded on the basis of ... were not correlated with the degree of anatomic change in the lungs as seen on x-ray examination the largest percentage differences ...

Background: Nearly 30% of all exacerbations of COPD do not have a clear etiology. Although pulmonary embolism (PE) can exacerbate respiratory symptoms such as dyspnea and chest pain, and COPD ...

Introduction COPD is a chronic, progressive, inflammatory disease of the lungs and the third leading cause of death worldwide. The current knowledge of the pathophysiology of COPD is limited and novel ...

A study was undertaken to examine the associations between lung function impairment and COPD hospitalisation, and COPD hospitalisation and mortality. Methods The analysis included a population-based ...

a COPD flare, or severe bronchitis various procedures to drain the pleural cavity of fluid surgery to treat lung problems such as cancer or an abscess COPD is incurable, but treatment can help ...

People with COPD experience changes in their bodies. It starts with damage to the airways and tiny sacs in your lungs. That progresses to a wet cough and difficulty breathing, which can then get ...

Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory disease of the lungs that makes it more difficult to breathe over time. The disease causes changes to the tissues inside ...

In idiopathic pulmonary fibrosis (IPF) patients, alveolar epithelium architectures are persistently lost and lung gas transfer function would decline over time, which cannot be rescued by conventional ...